Skip to main content

Table 2 Incidence of central nervous system (CNS) relapses in patients with breast cancer and types other of solid tumor according to the administered chemotherapy regimen

From: Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status

Patients

CNS relapses

P value

 

n

Percentage

 

Group A (n = 305)

39

12.8

0.024a

Group B (n = 187)

12

6.5

 

Group C (n = 416)

32

7.6

0.196b

Group D (n = 137)

9

6.5

 
  1. Group A, patients with breast cancer treated with a taxane-containing regimen; group B, patients with breast cancer treated with a nontaxane-containing regimen; group C, patients with another type of solid tumor type treated with a taxane-containing regimen; and group D, patients with another type of solid tumor treated with a nontaxane-containing regimen. a P value corresponds to the incidence of CNS relapses between groups A and B. b P value corresponds to the incidence of CNS relapses between groups C and D.
Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us